FDA's Robot Surgery Approval Cheat Sheet Drops for Makers
Published Date: 9/25/2026
Notice
Summary
The FDA just dropped a draft guide for companies making robot-assisted surgical devices, showing how to get their products approved before selling. If you’re in the biz, now’s the time to check it out and send your feedback by November 24, 2026. This guide aims to make the approval process clearer and smoother, potentially saving time and money down the road.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Draft recommendations for RASD premarket tests
If you make robotically-assisted surgical devices (RASDs), the FDA released a draft guidance that gives recommendations for non-clinical and clinical testing and for what to include in premarket submissions. The document says these recommendations are intended to promote consistency and facilitate efficient review of premarket submissions.
Opportunity to comment by Nov 24, 2026
Stakeholders can submit electronic or written comments on the draft guidance; comments must be submitted by November 24, 2026 for consideration before FDA begins work on the final guidance. Comments may be submitted at https://www.regulations.gov (Docket No. FDA-2026-N-9505) or as written/paper submissions to FDA's Dockets Management Staff.
Draft guidance is nonbinding and optional
The FDA states the draft guidance is not final or for implementation and, when finalized, will represent the Agency's current thinking. You may use an alternative approach if it satisfies applicable statutes and regulations.
No new paperwork collections under PRA
The guidance states it contains no new collection of information under the Paperwork Reduction Act and instead refers to previously OMB-approved FDA collections, including control numbers 0910-0120, 0910-0231, 0910-0078, 0910-0844, 0910-0756, 0910-0485, 0910-0073, 0910-0449, 0910-0130, and 0910-0119.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2026-19703, Intent to Request an Revision From OMB of One Current Public Collection of Information: Law Enforcement Officers (LEOs) Flying Armed
The TSA is updating how it collects info from armed law enforcement officers flying on planes to keep everyone safe and speed up security checks. This affects federal, state, and local officers who fly armed and aims to make the process clearer and less of a hassle. Public comments are open until November 24, 2026, with no new costs expected, just smoother info gathering.
Next: 2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!